7/1/2026 Categories: Industries Angelini Industries: total revenues reach €1.7 billion (+4.6%). Growth in pharmaceuticals and industrial technology
5/13/2021 Training at the service of talent: the second edition of the Angelini Future Leaders Program gets underway
5/12/2021 ISTAO e UNITRE present the event “ANGELINI: protagonists of the Italian pharmaceutical industry”
1/4/2021 Categories: Pharma Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
12/22/2020 Categories: Consumer Goods MadreNatura and Angelini Foundation: food adoption kicks off in collaboration with Banco Alimentare Lombardia and Abruzzo
12/1/2020 Sergio Marullo di Condojanni (Angelini Holding) participates in the G20 Business Summit - B20
Angelini Industries
